echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > AJH: Hyperoxia-affinity hemoglobinopathies-associated polycythemia: 41 cases of clinical outcome and treatment impact

    AJH: Hyperoxia-affinity hemoglobinopathies-associated polycythemia: 41 cases of clinical outcome and treatment impact

    • Last Update: 2021-10-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The HOA hemoglobin variant was first described by Virgil Fairbanks in 1971


    HOA hemoglobin variant HOA hemoglobin variant thrombosis management

    A foreign expert team tried to clarify these issues by studying current characteristics, treatment strategies and follow-up events.


    During the 10-year median follow-up, 23 (56%) patients reported one or more symptoms that were thought to be related to elevated Hct, and 10 (24%) patients recorded thrombosis


    In summary, the current research does not imply that Hgb/Hct levels are the main contributor to the incidence of HOA hemoglobinopathies-associated polycythemia, and indicates that the value of bloodletting therapy is limited


    The current research does not imply that Hgb/Hct levels are the main contributor to the incidence of HOA hemoglobinopathies-associated polycythemia, and indicates that the value of bloodletting therapy is limited


    Original source:

    Original source:

    Gangat N, Oliveira JL, Hoyer JD, Patnaik MM, Pardanani A, Tefferi A.


    Gangat N, Oliveira JL, Hoyer JD, Patnaik MM, Pardanani A, Tefferi A.
    High-oxygen-affinity hemoglobinopathy-associated erythrocytosis: clinical outcomes and impact of therapy in 41 cases.
    Am J Hematol.
    2021 Oct 11.
    doi: 10.
    1002/ ajh.
    26375.
    Epub ahead of print.
    PMID: 34633117.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.